eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple myeloma |
| Comorbidity | C0035078|renal failure |
| Sentences | 35 |
| PubMedID- 24895606 | Early articles linked iv administration of contrast agents with the development of renal failure in patients with multiple myeloma, leading to the conclusion that iv contrast media are contraindicated in patients with myeloma because they are at a high risk for developing cin [97–101]. |
| PubMedID- 25816886 | Chemotherapy with or without plasmapheresis in acute renal failure due to multiple myeloma: a meta-analysis. |
| PubMedID- 22041268 | And one patient had myeloma cast nephropathy with acute renal failure. |
| PubMedID- 23656195 | Down-regulation of microrna-29c is associated with renal failure in multiple myeloma. |
| PubMedID- 23712232 | Effectiveness of haemodiafiltration with ultrafiltrate regeneration in renal failure due to multiple myeloma. |
| PubMedID- 25329484 | Aim of this review is to provide an overview of treatments of multiple myeloma patients with acute renal failure coming from most recent clinical trials. |
| PubMedID- 21511832 | Myeloma kidney is the major cause of severe irreversible renal failure in patients with multiple myeloma. |
| PubMedID- 20689322 | Background: the presence of renal failure in patients with multiple myeloma (mm) has been considered an ominous prognostic factor associated with a significantly decreased life expectancy. |
| PubMedID- 26390728 | [dialysis-dependent renal failure in patients with multiple myeloma: reversibility factors]. |
| PubMedID- 21188171 | There were two grade 4 renal failures in patients with multiple myeloma (mm). |
| PubMedID- 19693498 | Acute renal failure in patients with multiple myeloma (mm) requiring dialysis is a serious complication and is associated with extremely poor survival. |
| PubMedID- 25285800 | Efficacy, toxicity and mortality of autologous sct in multiple myeloma patients with dialysis-dependent renal failure. |
| PubMedID- 26124916 | Immunoglobulin d multiple myeloma with rapidly progressing renal failure. |
| PubMedID- 23591252 | Cast nephropathy is one of the major causes of renal failure in patients with multiple myeloma resulting from precipitation of free light chains inside the tubules. |
| PubMedID- 22260636 | Background: the aim of this cross-sectional study was to evaluate multiple myeloma patients presenting with renal failure in a university hospital. |
| PubMedID- 21368487 | [safety evaluation of bortezomib in multiple myeloma patients with severe renal failure]. |
| PubMedID- 26022018 | renal failure in patients with multiple myeloma. |
| PubMedID- 22920640 | The primary cause of renal failure in myeloma is damage to the kidney by excessive amounts of light chain produced by the myeloma tumor, giving rise to cast nephropathy (myeloma kidney), although there are several other important precipitants. |
| PubMedID- 23249872 | renal failure in multiple myeloma is frequent, and portends a dismal prognosis. |
| PubMedID- 24877060 | Pathogenesis of renal failure in multiple myeloma: any role of contrast media. |
| PubMedID- 25018923 | Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide. |
| PubMedID- 24385726 | Among patients diagnosed as myeloma, 25% present with acute renal failure (arf) [3,4,5,6]. |
| PubMedID- 22889516 | Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy. |
| PubMedID- 20955270 | multiple myeloma complicated by acute renal failure is a diagnosis often encountered by the practicing nephrologist. |
| PubMedID- 23705905 | Current treatments for renal failure due to multiple myeloma. |
| PubMedID- 21175542 | Aggressive removal of circulating free light chains (flc) by blood purification accompanied by chemotherapy is a promising approach for the treatment of acute renal failure due to myeloma cast nephropathy. |
| PubMedID- 21264915 | High-dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma. |
| PubMedID- 21358693 | Plerixafor for pbsc mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from europe and the usa. |
| PubMedID- 25089594 | Bortezomib improves outcome after sct in multiple myeloma patients with end-stage renal failure. |
| PubMedID- 21339749 | renal failure in multiple myeloma: a medical emergency. |
| PubMedID- 21515102 | [new insights in the treatment of myeloma with renal failure]. |
| PubMedID- 25671952 | Conclusions: iss stage and renal failure due to multiple myeloma at presentation have a significant impact on survival. |
| PubMedID- 20835325 | Complete remission of lambda light chain myeloma presenting with acute renal failure following treatment with bortezomib and steroids. |
| PubMedID- 23597473 | [clinical study of bortezomib in the treatment of multiple myeloma patients with renal failure]. |
| PubMedID- 26154652 | The cases include non-adherent patients who discontinued their immunosuppressive medications, transplantation between identical twins, kidney transplantation after a successful bone marrow graft from the same donor and simultaneous bone marrow and kidney transplantation for the treatment of multiple myeloma with associated renal failure. |
Page: 1